<DOC>
	<DOCNO>NCT00628017</DOCNO>
	<brief_summary>This preliminary study aim investigate whether feasible conduct study use fish oil compare placebo ( olive oil ) people cognitive impairment . We also explore whether fish oil well efficacy clinical aspect people cognitive impairment 24 week intervention . The major clinical outcome : 1. general clinical impression 2. cognitive function</brief_summary>
	<brief_title>Preliminary Study Fish Oil Dementia</brief_title>
	<detailed_description>Despite positive finding observational animal study , effect n-3 PUFA administration cognitive impairment human receive little evaluation date . Although clinical trial fish oil report , result inconsistent . Given inconsistent finding , carry preliminary study investigate effect fish oil monotherapy cognitive function general clinical condition patient cognitive impairment .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>fulfil diagnosis AD accord American Psychiatric Association , DSMIV criterion , mild moderate severity ( define Mini Mental Status Examination ( MMSE ) score 10 26 , Clinical Dementia Rating ( CDR ) score 1 2 . ) amnesic MCI ( define ( 1 ) . Subjective memory impairment patient /or informant , ( 2 ) objective memory impairment fall least 1.5 standard deviation age educationspecific norm Logical Memory delayedrecall score Wechsler Memory Scale III ( 3 ) relatively normal performance cognitive domain , ( 4 ) impairment activity daily live , ( 5 ) failure meet DSMIV criterion dementia . ) inadequate motor sensory capacity comply test ischemic lesion brain CT report radiologist modified Hachinski Ischemic Scale score &gt; 4 17item Hamilton Depression Scale ( HDRS ) score &gt; 13 abnormal level folic acid , vitamin B12 , thyroid function severe comorbidity , include another neurodegenerative disease , another chronic debilitate neurological illness ( e.g . cerebral palsy ) , brain trauma , tumor , severe pulmonary , renal , liver disease , cardiac disease , autoimmune disease , condition expect cause death within one year . Participants diagnosis alcoholism , schizophrenia , bipolar disorder exclude . Participants receive cholinesterase agent screen take NSAID longterm basis</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>polyunsaturated fatty acid</keyword>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>mild cognitive impairment</keyword>
	<keyword>fish oil</keyword>
	<keyword>cognition</keyword>
</DOC>